Table of Contents Global RNA Based Therapeutics Market Professional Survey Report 2017 1 Industry Overview of RNA Based Therapeutics 1.1 Definition and Specifications of RNA Based Therapeutics 1.1.1 Definition of RNA Based Therapeutics 1.1.2 Specifications of RNA Based Therapeutics 1.2 Classification of RNA Based Therapeutics 1.2.1 Global RNA Based Therapeutics Production (K Units) and Growth Rate (%) Comparison by Types (2012-2023) 1.2.2 Global RNA Based Therapeutics Production Market Share (%) by Types in 2017 1.2.3 Microarrays 1.2.4 Labeling 1.2.5 Purification 1.2.6 Linear amplification 1.2.7 qRT-PCR 1.2.6 Inhibition 1.2.7 ????RNA Interference (RNAi) technologies 1.2.8 ????RNA antisense technologies 1.3 Applications of RNA Based Therapeutics 1.3.1 Global RNA Based Therapeutics Consumption (K Units) Comparison by Applications (2012-2023) 1.3.2 Cardiovascular 1.3.3 Kidney Diseases 1.3.4 Oncology 1.3.5 Infectious diseases 1.3.6 Metabolic disorders 1.3.6 Others 1.4 Global RNA Based TherapeuticsMarket by Regions (2012-2023) 1.4.1 Global RNA Based Therapeutics Market Size and Growth Rate (%) Comparison by Regions (2012-2023) 1.4.2 North AmericaRNA Based Therapeutics Status and Prospect (2012-2023) 1.4.3 EuropeRNA Based Therapeutics Status and Prospect (2012-2023) 1.4.4 ChinaRNA Based Therapeutics Status and Prospect (2012-2023) 1.4.5 JapanRNA Based Therapeutics Status and Prospect (2012-2023) 1.4.6 Southeast AsiaRNA Based Therapeutics Status and Prospect (2012-2023) 1.5 Global RNA Based Therapeutics Market Size (2012-2023) 1.5.1 Global RNA Based Therapeutics Revenue (Million USD) Status and Outlook (2012-2023) 1.5.2 Global RNA Based Therapeutics Capacity, Production (K Units) Status and Outlook (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of RNA Based Therapeutics 2.2 Raw Material Analysis of RNA Based Therapeutics 2.2.1 Raw Material A Market Analysis 2.2.2 Raw Material B Market Analysis 2.2.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of RNA Based Therapeutics 2.4 Other Costs Analysis of RNA Based Therapeutics 2.5 Manufacturing Cost Structure Analysis of RNA Based Therapeutics 2.6 Manufacturing Process Analysis of RNA Based Therapeutics 2.7 Raw Materials Sources of RNA Based Therapeutics Major Manufacturers in 2017 2.8 Downstream Buyers of RNA Based Therapeutics 3 Global RNA Based Therapeutics Manufacturers Profiles/Analysis 3.1 Quark Pharmaceuticals 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 RNA Based Therapeutics Product Category, Application and Specification 3.1.2.1 Microarrays 3.1.2.2 Labeling 3.1.2.3 Purification 3.1.3 Quark Pharmaceuticals 2017 RNA Based Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.1.4 Quark Pharmaceuticals 2017 Business Region Distribution Analysis 3.1.5 Quark Pharmaceuticals RNA Based Therapeutics Volume in Different Applications and Its Application Share 3.2 Alnylam Pharmaceuticals 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 RNA Based Therapeutics Product Category, Application and Specification 3.2.2.1 Microarrays 3.2.2.2 Labeling 3.2.2.3 Purification 3.2.3 Alnylam Pharmaceuticals 2017 RNA Based Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.2.4 Alnylam Pharmaceuticals 2017 Business Region Distribution Analysis 3.2.5 Alnylam Pharmaceuticals RNA Based Therapeutics Volume in Different Applications and Its Application Share 3.3 Dicerna Pharmaceuticals 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 RNA Based Therapeutics Product Category, Application and Specification 3.3.2.1 Microarrays 3.3.2.2 Labeling 3.3.2.3 Purification 3.3.3 Dicerna Pharmaceuticals 2017 RNA Based Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.3.4 Dicerna Pharmaceuticals 2017 Business Region Distribution Analysis 3.3.5 Dicerna Pharmaceuticals RNA Based Therapeutics Volume in Different Applications and Its Application Share 3.4 Tekmira Pharmaceuticals 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 RNA Based Therapeutics Product Category, Application and Specification 3.4.2.1 Microarrays 3.4.2.2 Labeling 3.4.2.3 Purification 3.4.3 Tekmira Pharmaceuticals 2017 RNA Based Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.4.4 Tekmira Pharmaceuticals 2017 Business Region Distribution Analysis 3.4.5 Tekmira Pharmaceuticals RNA Based Therapeutics Volume in Different Applications and Its Application Share 3.5 Benitec Biopharma Limited 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 RNA Based Therapeutics Product Category, Application and Specification 3.5.2.1 Microarrays 3.5.2.2 Labeling 3.5.2.3 Purification 3.5.3 Benitec Biopharma Limited 2017 RNA Based Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.5.4 Benitec Biopharma Limited 2017 Business Region Distribution Analysis 3.5.5 Benitec Biopharma Limited RNA Based Therapeutics Volume in Different Applications and Its Application Share 3.6 Genzyme Corporation 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 RNA Based Therapeutics Product Category, Application and Specification 3.6.2.1 Microarrays 3.6.2.2 Labeling 3.6.2.3 Purification 3.6.3 Genzyme Corporation RNA Based Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.6.4 Genzyme Corporation 2017 Business Region Distribution Analysis 3.6.5 Genzyme Corporation RNA Based Therapeutics Volume in Different Applications and Its Application Share 3.7 ISIS pharmaceuticals 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 RNA Based Therapeutics Product Category, Application and Specification 3.7.2.1 Microarrays 3.7.2.2 Labeling 3.7.2.3 Purification 3.7.3 ISIS pharmaceuticals 2017 RNA Based Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.7.4 ISIS pharmaceuticals 2017 Business Region Distribution Analysis 3.7.5 ISIS pharmaceuticals RNA Based Therapeutics Volume in Different Applications and Its Application Share 3.8 Silence Therapeutics 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 RNA Based Therapeutics Product Category, Application and Specification 3.8.2.1 Microarrays 3.8.2.2 Labeling 3.8.2.3 Purification 3.8.3 Silence Therapeutics 2017 RNA Based Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.8.4 Silence Therapeutics 2017 Business Region Distribution Analysis 3.8.5 Silence Therapeutics RNA Based Therapeutics Volume in Different Applications and Its Application Share 3.9 Cenix BioScience 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 RNA Based Therapeutics Product Category, Application and Specification 3.9.2.1 Microarrays 3.9.2.2 Labeling 3.9.2.3 Purification 3.9.3 Cenix BioScience 2017 RNA Based Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.9.4 Cenix BioScience 2017 Business Region Distribution Analysis 3.9.5 Cenix BioScience RNA Based Therapeutics Volume in Different Applications and Its Application Share 3.10.2.1 Microarrays 3.10.2.2 Labeling 3.10.2.3 Purification 4 Technical Data and Manufacturing Plants Analysis of RNA Based Therapeutics 4.1 Capacity and Commercial Production Date of Global RNA Based Therapeutics Major Manufacturers in 2017 4.2 Manufacturing Plants Distribution of Global RNA Based Therapeutics Major Manufacturers in 2017 4.4 R&D Status and Technology Source of Global RNA Based Therapeutics Major Manufacturers in 2017 4.4 Raw Materials Sources Analysis of Global RNA Based Therapeutics Major Manufacturers in 2017 5 Global RNA Based Therapeutics Overall Market Overview 5.1 2012-2017 Overall Market Analysis 5.2 Capacity Analysis 5.2.1 2012-2017 Global RNA Based Therapeutics Capacity and Growth Rate Analysis 5.2.2 2017 RNA Based Therapeutics Capacity Analysis (Company Segment) 5.3 Sales Analysis 5.3.1 2012-2017 Global RNA Based Therapeutics Sales and Growth Rate Analysis 5.3.2 2017 RNA Based Therapeutics Sales Analysis (Company Segment) 5.4 Sales Price Analysis 5.4.1 2012-2017 Global RNA Based Therapeutics Sales Price 5.4.2 2017 RNA Based Therapeutics Sales Price Analysis (Company Segment) 6 RNA Based Therapeutics Regional Market Analysis 6.1 North America RNA Based Therapeutics Market Analysis 6.1.1 North America RNA Based Therapeutics Market Overview 6.1.2 North America 2012-2017 RNA Based Therapeutics Local Supply, Import, Export, Local Consumption Analysis 6.1.3 North America 2012-2017 RNA Based Therapeutics Sales Price Analysis 6.1.4 North America 2017 RNA Based Therapeutics Market Share Analysis 6.2 Europe RNA Based Therapeutics Market Analysis 6.2.1 Europe RNA Based Therapeutics Market Overview 6.2.2 Europe 2012-2017 RNA Based Therapeutics Local Supply, Import, Export, Local Consumption Analysis 6.2.3 Europe 2012-2017 RNA Based Therapeutics Sales Price Analysis 6.2.4 Europe 2017 RNA Based Therapeutics Market Share Analysis 6.3 China RNA Based Therapeutics Market Analysis 6.3.1 China RNA Based Therapeutics Market Overview 6.3.2 China 2012-2017 RNA Based Therapeutics Local Supply, Import, Export, Local Consumption Analysis 6.3.3 China 2012-2017 RNA Based Therapeutics Sales Price Analysis 6.3.4 China 2017 RNA Based Therapeutics Market Share Analysis 6.4 Japan RNA Based Therapeutics Market Analysis 6.4.1 Japan RNA Based Therapeutics Market Overview 6.4.2 Japan 2012-2017 RNA Based Therapeutics Local Supply, Import, Export, Local Consumption Analysis 6.4.3 Japan 2012-2017 RNA Based Therapeutics Sales Price Analysis 6.4.4 Japan 2017 RNA Based Therapeutics Market Share Analysis 6.5 Southeast Asia RNA Based Therapeutics Market Analysis 6.5.1 Southeast Asia RNA Based Therapeutics Market Overview 6.5.2 Southeast Asia 2012-2017 RNA Based Therapeutics Local Supply, Import, Export, Local Consumption Analysis 6.5.3 Southeast Asia 2012-2017 RNA Based Therapeutics Sales Price Analysis 6.5.4 Southeast Asia 2017 RNA Based Therapeutics Market Share Analysis 6.6 India RNA Based Therapeutics Market Analysis 6.6.1 India RNA Based Therapeutics Market Overview 6.6.2 India 2012-2017 RNA Based Therapeutics Local Supply, Import, Export, Local Consumption Analysis 6.6.3 India 2012-2017 RNA Based Therapeutics Sales Price Analysis 6.6.4 India 2017 RNA Based Therapeutics Market Share Analysis 7 Global 2012-2017 RNA Based Therapeutics Segment Market Analysis (by Type) 7.1 Global 2012-2017 RNA Based Therapeutics Sales by Type 7.2 Different Types of RNA Based Therapeutics Product Interview Price Analysis 7.3 Different Types of RNA Based Therapeutics Product Driving Factors Analysis 7.3.1 Microarrays of RNA Based Therapeutics Growth Driving Factor Analysis 7.3.2 Labeling of RNA Based Therapeutics Growth Driving Factor Analysis 7.3.3 Purification of RNA Based Therapeutics Growth Driving Factor Analysis 7.3.4 Linear amplification of RNA Based Therapeutics Growth Driving Factor Analysis 7.3.5 qRT-PCR of RNA Based Therapeutics Growth Driving Factor Analysis 8 Global 2012-2017 RNA Based Therapeutics Segment Market Analysis (by Application) 8.1 Global 2012-2017 RNA Based Therapeutics Consumption by Application 8.2 Different Application of RNA Based Therapeutics Product Interview Price Analysis 8.3 Different Application of RNA Based Therapeutics Product Driving Factors Analysis 8.3.1 Cardiovascular of RNA Based Therapeutics Growth Driving Factor Analysis 8.3.2 Kidney Diseases of RNA Based Therapeutics Growth Driving Factor Analysis 8.3.3 Oncology of RNA Based Therapeutics Growth Driving Factor Analysis 8.3.4 Infectious diseases of RNA Based Therapeutics Growth Driving Factor Analysis 8.3.5 Metabolic disorders of RNA Based Therapeutics Growth Driving Factor Analysis 9 Development Trend of Analysis of RNA Based Therapeutics Market 9.1 Global RNA Based Therapeutics Market Trend Analysis 9.1.1 Global 2018-2023 RNA Based Therapeutics Market Size (Volume and Value) Forecast 9.1.2 Global 2018-2023 RNA Based Therapeutics Sales Price Forecast 9.2 RNA Based Therapeutics Regional Market Trend 9.2.1 North America 2018-2023 RNA Based Therapeutics Consumption Forecast 9.2.2 Europe 2018-2023 RNA Based Therapeutics Consumption Forecast 9.2.3 China 2018-2023 RNA Based Therapeutics Consumption Forecast 9.2.4 Japan 2018-2023 RNA Based Therapeutics Consumption Forecast 9.2.5 Southeast Asia 2018-2023 RNA Based Therapeutics Consumption Forecast 9.2.6 India 2018-2023 RNA Based Therapeutics Consumption Forecast 9.3 RNA Based Therapeutics Market Trend (Product Type) 9.4 RNA Based Therapeutics Market Trend (Application) 10 Marketing Strategy Analysis, Distributors/Traders 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List 11 RNA Based Therapeutics Marketing Type Analysis 11.1 RNA Based Therapeutics Regional Marketing Type Analysis 11.2 RNA Based Therapeutics International Trade Type Analysis 11.3 Traders or Distributors with Contact Information of RNA Based Therapeutics by Region 11.4 RNA Based Therapeutics Supply Chain Analysis 12 Consumers Analysis of RNA Based Therapeutics 12.1 Consumer 1 Analysis 12.2 Consumer 2 Analysis 12.3 Consumer 3 Analysis 12.4 Consumer 4 Analysis 13 Conclusion of the Global RNA Based Therapeutics Market Professional Survey Report 2018 14 Methodology and Data Source 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer 14.4 Author List

List of Tables and Figures Figure Global Market Size (Million USD) Status and Outlook 2012-2023 Table Global RNA Based Therapeutics Revenue (Million USD) Comparison by Regions (2012-2023) Table Global RNA Based Therapeutics Production (K Units) and Revenue (Million USD) Market Split by Product Type Table Global RNA Based Therapeutics Consumption (K Units) by Application (2016-2023) Figure Picture of RNA Based Therapeutics Table Product Specifications of RNA Based Therapeutics Table Global RNA Based Therapeutics Production (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Global RNA Based Therapeutics Production Market Share (%) by Types in 2017 Figure Microarrays Picture Table Major Manufacturers of Microarrays Figure Labeling Picture Table Major Manufacturers of Labeling Figure Purification Picture Table Major Manufacturers of Purification Table Global RNA Based Therapeutics Consumption (K Units) Comparison by Applications (2012-2023) Figure Global RNA Based Therapeutics Consumption (K Units) Market Share (%) by Applications in 2017 Figure Cardiovascular Picture Figure Kidney Diseases Picture Figure Oncology Picture Table Global RNA Based Therapeutics Revenue (Million USD) Comparison by Regions (2012-2023) Figure North America RNA Based Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe RNA Based Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure China RNA Based Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Southeast Asia RNA Based Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure India RNA Based Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Japan RNA Based Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Global RNA Based Therapeutics Revenue (Million USD) Status and Outlook (2012-2023) Figure Global RNA Based Therapeutics Capacity, Production (K Units) Status and Outlook (2012-2023) Figure Industry Chain Structure of RNA Based Therapeutics Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of RNA Based Therapeutics in 2017 Figure Manufacturing Process Analysis of RNA Based Therapeutics Table Raw Materials Sources of RNA Based Therapeutics Major Manufacturers in 2017 Table Major Buyers of RNA Based Therapeutics Table Quark Pharmaceuticals Information List Table Microarrays RNA Based Therapeutics Overview Table Labeling RNA Based Therapeutics Overview Table Purification RNA Based Therapeutics Overview Table 2017 Quark Pharmaceuticals RNA Based Therapeutics Revenue, Sales, Ex-factory Price Figure 2017 Quark Pharmaceuticals RNA Based Therapeutics Business Region Distribution Table Microarrays Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Labeling Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Purification Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Quark Pharmaceuticals RNA Based Therapeutics Volume in Cardiovascular and Its Application Share Table Quark Pharmaceuticals RNA Based Therapeutics Volume in Kidney Diseases and Its Application Share Table Quark Pharmaceuticals RNA Based Therapeutics Volume in Oncology and Its Application Share Table Alnylam Pharmaceuticals Information List Table Microarrays RNA Based Therapeutics Overview Table Labeling RNA Based Therapeutics Overview Table Purification RNA Based Therapeutics Overview Table 2017 Alnylam Pharmaceuticals RNA Based Therapeutics Revenue, Sales, Ex-factory Price Figure 2017 Alnylam Pharmaceuticals RNA Based Therapeutics Business Region Distribution Table Microarrays Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Labeling Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Purification Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Alnylam Pharmaceuticals RNA Based Therapeutics Volume in Cardiovascular and Its Application Share Table Alnylam Pharmaceuticals RNA Based Therapeutics Volume in Kidney Diseases and Its Application Share Table Alnylam Pharmaceuticals RNA Based Therapeutics Volume in Oncology and Its Application Share Table Dicerna Pharmaceuticals Information List Table Microarrays RNA Based Therapeutics Overview Table Labeling RNA Based Therapeutics Overview Table 2017 Dicerna Pharmaceuticals RNA Based Therapeutics Revenue, Sales, Ex-factory Price Figure 2017 Dicerna Pharmaceuticals RNA Based Therapeutics Business Region Distribution Table Microarrays Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Labeling Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Purification Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dicerna Pharmaceuticals RNA Based Therapeutics Volume in Cardiovascular and Its Application Share Table Dicerna Pharmaceuticals RNA Based Therapeutics Volume in Kidney Diseases and Its Application Share Table Dicerna Pharmaceuticals RNA Based Therapeutics Volume in Oncology and Its Application Share Table Tekmira Pharmaceuticals Information List Table Microarrays RNA Based Therapeutics Overview Table Labeling RNA Based Therapeutics Overview Table Purification RNA Based Therapeutics Overview Table 2017 Tekmira Pharmaceuticals RNA Based Therapeutics Revenue, Sales, Ex-factory Price Figure 2017 Tekmira Pharmaceuticals RNA Based Therapeutics Business Region Distribution Table Microarrays Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Labeling Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Purification Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Tekmira Pharmaceuticals RNA Based Therapeutics Volume in Cardiovascular and Its Application Share Table Tekmira Pharmaceuticals RNA Based Therapeutics Volume in Kidney Diseases and Its Application Share Table Tekmira Pharmaceuticals RNA Based Therapeutics Volume in Oncology and Its Application Share Table Benitec Biopharma Limited Information List Table Microarrays RNA Based Therapeutics Overview Table Labeling RNA Based Therapeutics Overview Table 2017 Benitec Biopharma Limited RNA Based Therapeutics Revenue, Sales, Ex-factory Price Figure 2017 Benitec Biopharma Limited RNA Based Therapeutics Business Region Distribution Table Microarrays Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Labeling Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Purification Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Benitec Biopharma Limited RNA Based Therapeutics Volume in Cardiovascular and Its Application Share Table Benitec Biopharma Limited RNA Based Therapeutics Volume in Kidney Diseases and Its Application Share Table Benitec Biopharma Limited RNA Based Therapeutics Volume in Oncology and Its Application Share Table Genzyme Corporation Information List Table Microarrays RNA Based Therapeutics Overview Table Labeling RNA Based Therapeutics Overview Table 2017 Genzyme Corporation RNA Based Therapeutics Revenue, Sales, Ex-factory Price Figure 2017 Genzyme Corporation RNA Based Therapeutics Business Region Distribution Table Microarrays Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Labeling Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Purification Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Genzyme Corporation RNA Based Therapeutics Volume in Cardiovascular and Its Application Share Table Genzyme Corporation RNA Based Therapeutics Volume in Kidney Diseases and Its Application Share Table Genzyme Corporation RNA Based Therapeutics Volume in Oncology and Its Application Share Table ISIS pharmaceuticals Information List Table Microarrays RNA Based Therapeutics Overview Table Labeling RNA Based Therapeutics Overview Table 2017 ISIS pharmaceuticals RNA Based Therapeutics Revenue, Sales, Ex-factory Price Figure 2017 ISIS pharmaceuticals RNA Based Therapeutics Business Region Distribution Table Microarrays Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Labeling Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Purification Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table ISIS pharmaceuticals RNA Based Therapeutics Volume in Kidney Diseases and Its Application Share Table ISIS pharmaceuticals RNA Based Therapeutics Volume in Oncology and Its Application Share Table Silence Therapeutics Information List Table Microarrays RNA Based Therapeutics Overview Table Labeling RNA Based Therapeutics Overview Table 2017 Silence Therapeutics RNA Based Therapeutics Revenue, Sales, Ex-factory Price Figure 2017 Silence Therapeutics RNA Based Therapeutics Business Region Distribution Table Microarrays Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Labeling Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Purification Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Silence Therapeutics RNA Based Therapeutics Volume in Cardiovascular and Its Application Share Table Silence Therapeutics RNA Based Therapeutics Volume in Kidney Diseases and Its Application Share Table Silence Therapeutics RNA Based Therapeutics Volume in Oncology and Its Application Share Table Cenix BioScience Information List Table Microarrays RNA Based Therapeutics Overview Table Labeling RNA Based Therapeutics Overview Table 2017 Cenix BioScience RNA Based Therapeutics Revenue, Sales, Ex-factory Price Figure 2017 Cenix BioScience RNA Based Therapeutics Business Region Distribution Table Microarrays Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Labeling Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Purification Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cenix BioScience RNA Based Therapeutics Volume in Cardiovascular and Its Application Share Table Cenix BioScience RNA Based Therapeutics Volume in Kidney Diseases and Its Application Share Table Cenix BioScience RNA Based Therapeutics Volume in Oncology and Its Application Share Table Information List Table Microarrays RNA Based Therapeutics Overview Table Labeling RNA Based Therapeutics Overview Table 2017 RNA Based Therapeutics Revenue, Sales, Ex-factory Price Figure 2017 RNA Based Therapeutics Business Region Distribution Table Microarrays Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Labeling Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Purification Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table RNA Based Therapeutics Volume in Cardiovascular and Its Application Share Table RNA Based Therapeutics Volume in Kidney Diseases and Its Application Share Table RNA Based Therapeutics Volume in Oncology and Its Application Share Table Capacity (K Units) and Commercial Production Date of Global RNA Based Therapeutics Major Manufacturers in 2017 Table Manufacturing Plants Distribution of Global RNA Based Therapeutics Major Manufacturers in 2017 Table R&D Status and Technology Source of Global RNA Based Therapeutics Major Manufacturers in 2017 Table Raw Materials Sources Analysis of Global RNA Based Therapeutics Major Manufacturers in 2017 Table Global Capacity (K Units), Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Sales Revenue (M USD) and Gross Margin of RNA Based Therapeutics 2012-2017 Figure Global 2012-2017 RNA Based Therapeutics Sales (K Units) and Growth Rate Figure Global 2012-2017 RNA Based Therapeutics Market Size (Million USD) and Growth Rate Figure 2012-2017 Global RNA Based Therapeutics Capacity and Growth Rate Table 2017 Global RNA Based Therapeutics Capacity List (Company Segment) Figure 2012-2017 Global RNA Based Therapeutics Sales and Growth Rate Table 2017 Global RNA Based Therapeutics Sales List (Company Segment) Figure 2012-2017 Global RNA Based Therapeutics Sales Price Table 2017 Global RNA Based Therapeutics Sales Price List (Company Segment) Figure North America Capacity Overview Figure North America 2017 RNA Based Therapeutics Capacity Market Share Table North America Supply, Import, Export and Consumption of RNA Based Therapeutics 2012-2017 (K Units) Figure North America 2012-2017 RNA Based Therapeutics Sales Price (USD/Unit) Figure North America 2017 RNA Based Therapeutics Sales Market Share Figure Europe Capacity Overview Figure Europe 2017 RNA Based Therapeutics Capacity Market Share Table Europe Supply, Import, Export and Consumption of RNA Based Therapeutics 2012-2017 (K Units) Figure Europe 2012-2017 RNA Based Therapeutics Sales Price (USD/Unit) Figure North America 2017 RNA Based Therapeutics Sales Market Share Figure China Capacity Overview Figure China 2017 RNA Based Therapeutics Capacity Market Share Table China Supply, Import, Export and Consumption of RNA Based Therapeutics 2012-2017 (K Units) Figure China 2012-2017 RNA Based Therapeutics Sales Price (USD/Unit) Figure China 2017 RNA Based Therapeutics Sales Market Share Figure Japan Capacity Overview Figure Japan 2017 RNA Based Therapeutics Capacity Market Share Table Japan Supply, Import, Export and Consumption of RNA Based Therapeutics 2012-2017 (K Units) Figure Japan 2012-2017 RNA Based Therapeutics Sales Price (USD/Unit) Figure Japan 2017 RNA Based Therapeutics Sales Market Share Figure Southeast Asia Capacity Overview Figure Southeast Asia 2017 RNA Based Therapeutics Capacity Market Share Table Southeast Asia Supply, Import, Export and Consumption of RNA Based Therapeutics 2012-2017 (K Units) Figure Southeast Asia 2012-2017 RNA Based Therapeutics Sales Price (USD/Unit) Figure Southeast Asia 2017 RNA Based Therapeutics Sales Market Share Figure India Capacity Overview Figure India 2017 RNA Based Therapeutics Capacity Market Share Table India Supply, Import, Export and Consumption of RNA Based Therapeutics 2012-2017 (K Units) Figure India 2012-2017 RNA Based Therapeutics Sales Price (USD/Unit) Figure India 2017 RNA Based Therapeutics Sales Market Share Table Global 2012-2017 RNA Based Therapeutics Sales by Type Table Different Types RNA Based Therapeutics Product Interview Price Table Global 2012-2017 RNA Based Therapeutics Sales by Application Table Different Application RNA Based Therapeutics Product Interview Price Figure Global 2018-2023 RNA Based Therapeutics Sales (K Units) and Growth Rate Forecast Figure Global 2018-2023 RNA Based Therapeutics Market Size (Million USD) and Growth Rate Forecast Figure Global 2018-2023 RNA Based Therapeutics Sales Price (USD/Unit) Forecast Figure North America 2018-2023 RNA Based Therapeutics Consumption Volume and Growth Rate Forecast Figure Europe 2018-2023 RNA Based Therapeutics Consumption Volume and Growth Rate Forecast Figure China 2018-2023 RNA Based Therapeutics Consumption Volume and Growth Rate Forecast Figure Japan 2018-2023 RNA Based Therapeutics Consumption Volume and Growth Rate Forecast Figure Southeast Asia 2018-2023 RNA Based Therapeutics Consumption Volume and Growth Rate Forecast Figure India 2018-2023 RNA Based Therapeutics Consumption Volume and Growth Rate Forecast Table Global Sales Volume (K Units) of RNA Based Therapeutics by Labeling2018-2023 Table Global Consumption Volume (K Units) of RNA Based Therapeutics by Kidney Diseases2018-2023 Table Distributors/Traders List Table Traders or Distributors with Contact Information of RNA Based Therapeutics by Regions Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Quark Pharmaceuticals Alnylam Pharmaceuticals Dicerna Pharmaceuticals Tekmira Pharmaceuticals Benitec Biopharma Limited Genzyme Corporation ISIS pharmaceuticals Silence Therapeutics Cenix BioScience